CIK 0001217234
- Large accelerated filer
CareDx, Inc.
Sign in to watch- Ticker
- CDNA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943316839
- Phone
- +1 415-287-2300
- Business address
- 8000 MARINA BLVD, 4TH FLOOR, BRISBANE, CA, 94005
- Former names
- XDx, Inc., EXPRESSION DIAGNOSTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,807,663
- in 5 filings, $6.8M under 10b5-1 plans
Net −$6,807,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-05 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −2,188 | $46.15 | $101K | 106,575 |
| 2026-08-05 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −500 | $46.75 | $23K | 106,075 |
| 2026-08-05 | Bickerstaff George Director | Sale | −20,000 | $46.29 | $926K | 134,061 |
| 2026-08-04 | Goldberg Michael Director | Sale | −44,700 | $47.06 | $2.1M | 61,738 |
| 2026-08-04 | COURNOYER CHRISTINE Director | Sale 10b5-1 | −16,000 | $46.94 | $751K | 42,943 |
| 2026-07-16 | Valantine Hannah Director | Sale 10b5-1 | −28,679 | $36.14 | $1.0M | 36,786 |
| 2026-07-16 | Valantine Hannah Director | Sale 10b5-1 | −100 | $36.55 | $4K | 36,686 |
| 2026-07-16 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −50,000 | $36.11 | $1.8M | 721,448 |
| 2026-07-16 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −68,000 | $39.01 | $2.7M | 653,448 |
| 2026-06-29 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −39,900 | $29.24 | $1.2M | 661,959 |
| 2026-06-26 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −100 | $29.00 | $3K | 661,959 |
| 2026-06-15 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −17,683 | $24.03 | $425K | 631,959 |
| 2026-06-15 | Valantine Hannah Director | Sale 10b5-1 | −12,103 | $23.11 | $280K | 36,686 |
| 2026-06-11 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −21,998 | $24.02 | $528K | 649,642 |
| 2026-06-04 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −4,835 | $24.00 | $116K | 671,640 |
| 2026-05-15 | TORRES ARTHUR A Director | Sale | −6,484 | $19.89 | $129K | 38,665 |
| 2026-05-14 | TORRES ARTHUR A Director | Sale | −4,086 | $20.97 | $86K | 45,149 |
| 2026-05-05 | Novack Jeffrey Adam Secretary and General Counsel | Sale | −2,688 | $20.68 | $56K | 113,924 |
| 2026-04-16 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −10,282 | $21.12 | $217K | 676,475 |
| 2026-02-03 | Novack Jeffrey Adam Secretary and General Counsel | Sale | −4,441 | $20.56 | $91K | 125,364 |
Page 2 of 16 · 310 trades